122 related articles for article (PubMed ID: 10997892)
21. Assessing the acceptability of NORPLANT implants in four countries: findings from focus group research.
Zimmerman M; Haffey J; Crane E; Szumowski D; Alvarez F; Bhiromrut P; Brache V; Lubis F; Salah M; Shaaban M
Stud Fam Plann; 1990; 21(2):92-103. PubMed ID: 2112794
[TBL] [Abstract][Full Text] [Related]
22. Problems and prospects of implants as a contraceptive method in Bangladesh.
Rahman MM; Islam MN; Haque MA; Kamal GM
Asia Pac Popul J; 1994 Dec; 9(4):43-58. PubMed ID: 12290011
[TBL] [Abstract][Full Text] [Related]
23. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
Dunson TR; Blumenthal PD; Alvarez F; Brache V; Cochon L; Dalberth B; Glover L; Remsburg R; Vu K; Katz D
Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
[TBL] [Abstract][Full Text] [Related]
24. Attitudes towards contraceptive implants and injectables among present and former users in Singapore.
Singh K; Viegas OA; Ratnam SS
J Biosoc Sci; 1990 Jan; 22(1):1-11. PubMed ID: 2105323
[TBL] [Abstract][Full Text] [Related]
25. Nonmenstrual adverse events associated with subdermal contraceptive implants containing normegestrel and levonorgestrel.
Arowojolu AO; Ladipo OA
Afr J Med Med Sci; 2003 Mar; 32(1):27-31. PubMed ID: 15030062
[TBL] [Abstract][Full Text] [Related]
26. Cytokeratins 8, 18 and 19 in endometrial epithelial cells during the normal menstrual cycle and in women receiving Norplant.
Wonodirekso S; Au CL; Hadisaputra W; Affandi B; Rogers PA
Contraception; 1993 Nov; 48(5):481-93. PubMed ID: 7506133
[TBL] [Abstract][Full Text] [Related]
27. A 5-year clinical evaluation of Norplant implants in Senegal.
Ba MG; Moreau JC; Sokal D; Dunson R; Dao B; Kouedou D; Diadhiou F
Contraception; 1999 Jun; 59(6):377-81. PubMed ID: 10518232
[TBL] [Abstract][Full Text] [Related]
28. Women's satisfaction with Norplant as compared with oral contraceptives.
Eilers GM; Swanson TK
J Fam Pract; 1994 Jun; 38(6):596-600. PubMed ID: 8195734
[TBL] [Abstract][Full Text] [Related]
29. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
Clark DA; Wang S; Rogers P; Vince G; Affandi B
Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
[TBL] [Abstract][Full Text] [Related]
30. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
31. Hormonal implants: contraception for a new century.
Darney PD
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
[TBL] [Abstract][Full Text] [Related]
32. Norplant: reasons for discontinuation and side-effects.
Rehan N; Inayatullah A; Chaudhary I
Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):113-8. PubMed ID: 10943573
[TBL] [Abstract][Full Text] [Related]
33. Experience of Thai women in Bangkok with Norplant-2 implants.
Chompootaweep S; Kochagarn E; Tang-Usaha J; Theppitaksak B; Dusitsin N
Contraception; 1998 Oct; 58(4):221-5. PubMed ID: 9866003
[TBL] [Abstract][Full Text] [Related]
34. First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants.
Sivin I; Lähteenmäki P; Mishell DR; Alvarez F; Diaz S; Ranta S; Grozinger C; Lacarra M; Brache V; Pavez M; Nash H; Stern J
Contraception; 1997 Nov; 56(5):317-21. PubMed ID: 9437561
[TBL] [Abstract][Full Text] [Related]
35. The introduction and use of Norplant implants in Indonesia.
Tuladhar J; Donaldson PJ; Noble J
Stud Fam Plann; 1998 Sep; 29(3):291-9. PubMed ID: 9789322
[TBL] [Abstract][Full Text] [Related]
36. Norplant subdermal contraceptive system: experience in Taiwan.
Tseng LH; Lee TY; Yang YS; Ko TM; Chuang SM
Contraception; 1996 Mar; 53(3):177-80. PubMed ID: 8689883
[TBL] [Abstract][Full Text] [Related]
37. Endometrial angiogenic response in Norplant users.
Subakir SB; Hadisaputra W; Handoyo AE; Affandi B
Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of the pre-introduction of contraception by means of subcutaneous levonorgestrel implants in Burkina Faso].
Lankoande J; Ouedraogo A; Dao B; Ouedraogo CM; Bonane B; Toure B; Ouattara T; Kabore I; Millogo B; Kone B
Dakar Med; 1998; 43(1):79-82. PubMed ID: 9827162
[TBL] [Abstract][Full Text] [Related]
39. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of safety, efficacy, and acceptability of NORPLANT implants in Sri Lanka.
Basnayake S; Thapa S; Balogh SA
Stud Fam Plann; 1988; 19(1):39-47. PubMed ID: 3129828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
